Nurosene Health Inc. (MNNDF) Comparison with companies in other sectors?

Nurosene Health Inc. has a share price of 43.85M. You can analyze Nurosene Health Inc. (MNNDF) competitors across different market sectors through stock heatmaps.

What are MNNDF's NET and operating margins?

Nurosene Health Inc. (MNNDF) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does MNNDF's earnings per share (EPS) trend reflect its financial momentum?

Nurosene Health Inc. (MNNDF) EPS is -0.22 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Nurosene Health Inc. is -1.48, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Nurosene Health Inc.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Nurosene Health Inc. like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

Nurosene Health Inc.

MNNDF•PNK

Healthcare

Medical - Healthcare Information Services

$0.33

$-0.03(-8.71%)

Nurosene Health Inc. (MNNDF) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$-0.22

P/E Ratio

-1.48

ROE

Net Margin

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$14.25M

Shares OutstandingTotal number of shares issued

$43.85M

Book Value/ShareNet worth per share

Revenue/ShareAnnual revenue per share

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-0.22

Net MarginNet income as percentage of revenue

Operating MarginOperating income as percentage of revenue

ROEReturn on shareholders' equity

ROAReturn on total assets

ROCEReturn on capital employed

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for MNNDFFinancial Ratios Analysis details for MNNDF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for MNNDFSector Benchmarking details for MNNDF are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Nurosene Health Inc. Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Nurosene Health Inc.. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Nurosene Health Inc.'s unique business strengths and challenges.

Key Financial Metrics for Nurosene Health Inc.

For Nurosene Health Inc., essential financial indicators include EPS -0.22, PE -1.48, and ROE -. These key ratios reveal insights into Nurosene Health Inc.'s profitability, valuation, and operational health. Understanding these metrics enables you to compare Nurosene Health Inc. with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Nurosene Health Inc.

Metrics like Net Margin - and ROA - shed light on how well Nurosene Health Inc. is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Nurosene Health Inc. can sustain its operations and continue growing in the future.

Valuation and Market Position of Nurosene Health Inc.

Using ratios such as P/B Ratio - and PEG Ratio -, investors can assess whether Nurosene Health Inc. is appropriately valued based on its financials and growth potential. These figures, combined with Nurosene Health Inc.'s market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Nurosene Health Inc.

Financial health indicators, such as Debt/Equity Ratio - and Cash Flow -, provide a snapshot of Nurosene Health Inc.'s ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Nurosene Health Inc., is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Nurosene Health Inc.

Investing in Nurosene Health Inc. based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Nurosene Health Inc. focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;